Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase.

Watashi K, Ishii N, Hijikata M, Inoue D, Murata T, Miyanari Y, Shimotohno K.

Mol Cell. 2005 Jul 1;19(1):111-22.

2.

Treating hepatitis C: can you teach old dogs new tricks?

Rice CM, You S.

Hepatology. 2005 Dec;42(6):1455-8.

PMID:
16317665
3.

Cyclophilin B escorts the hepatitis C virus RNA polymerase: a viral achilles heel?

Heitman J, Cullen BR.

Mol Cell. 2005 Jul 22;19(2):145-6. Review.

4.
5.

Identification of cellular and viral factors related to anti-hepatitis C virus activity of cyclophilin inhibitor.

Goto K, Watashi K, Inoue D, Hijikata M, Shimotohno K.

Cancer Sci. 2009 Oct;100(10):1943-50. doi: 10.1111/j.1349-7006.2009.01263.x. Epub 2009 Jun 26.

6.

Cyclophilin B stimulates RNA synthesis by the HCV RNA dependent RNA polymerase.

Heck JA, Meng X, Frick DN.

Biochem Pharmacol. 2009 Apr 1;77(7):1173-80. doi: 10.1016/j.bcp.2008.12.019. Epub 2009 Jan 6.

7.

Different mechanisms of hepatitis C virus RNA polymerase activation by cyclophilin A and B in vitro.

Weng L, Tian X, Gao Y, Watashi K, Shimotohno K, Wakita T, Kohara M, Toyoda T.

Biochim Biophys Acta. 2012 Dec;1820(12):1886-92. doi: 10.1016/j.bbagen.2012.08.017. Epub 2012 Aug 28.

PMID:
22954804
8.

Iron inactivates the RNA polymerase NS5B and suppresses subgenomic replication of hepatitis C Virus.

Fillebeen C, Rivas-Estilla AM, Bisaillon M, Ponka P, Muckenthaler M, Hentze MW, Koromilas AE, Pantopoulos K.

J Biol Chem. 2005 Mar 11;280(10):9049-57. Epub 2005 Jan 6.

9.

Diverse effects of cyclosporine on hepatitis C virus strain replication.

Ishii N, Watashi K, Hishiki T, Goto K, Inoue D, Hijikata M, Wakita T, Kato N, Shimotohno K.

J Virol. 2006 May;80(9):4510-20.

11.

RNAi expression mediated inhibition of HCV replication.

Hamazaki H, Ujino S, Abe E, Miyano-Kurosaki N, Shimotohno K, Takaku H.

Nucleic Acids Symp Ser (Oxf). 2004;(48):307-8.

PMID:
17150601
12.

Characterization of hepatitis C virus subgenomic replicon resistance to cyclosporine in vitro.

Robida JM, Nelson HB, Liu Z, Tang H.

J Virol. 2007 Jun;81(11):5829-40. Epub 2007 Mar 21.

13.
14.

Mutational Analysis of Hepatitis C Virus NS5B in the Subgenomic Replicon Cell Culture.

Ma Y, Shimakami T, Luo H, Hayashi N, Murakami S.

J Biol Chem. 2004 Jun 11;279(24):25474-82. Epub 2004 Mar 22.

15.

Regulation of hepatitis C virus replication by the core protein through its interaction with viral RNA polymerase.

Kang SM, Choi JK, Kim SJ, Kim JH, Ahn DG, Oh JW.

Biochem Biophys Res Commun. 2009 Aug 14;386(1):55-9. doi: 10.1016/j.bbrc.2009.05.129. Epub 2009 Jun 6.

PMID:
19501052
16.

Anti-hepatitis C virus activity of tamoxifen reveals the functional association of estrogen receptor with viral RNA polymerase NS5B.

Watashi K, Inoue D, Hijikata M, Goto K, Aly HH, Shimotohno K.

J Biol Chem. 2007 Nov 9;282(45):32765-72. Epub 2007 Aug 17.

17.

Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro.

Yang F, Robotham JM, Nelson HB, Irsigler A, Kenworthy R, Tang H.

J Virol. 2008 Jun;82(11):5269-78. doi: 10.1128/JVI.02614-07. Epub 2008 Apr 2.

18.

Involvement of cyclophilin B in the replication of Japanese encephalitis virus.

Kambara H, Tani H, Mori Y, Abe T, Katoh H, Fukuhara T, Taguwa S, Moriishi K, Matsuura Y.

Virology. 2011 Mar 30;412(1):211-9. doi: 10.1016/j.virol.2011.01.011. Epub 2011 Feb 1.

19.

Effect of hepatitis C virus (HCV) NS5B-nucleolin interaction on HCV replication with HCV subgenomic replicon.

Shimakami T, Honda M, Kusakawa T, Murata T, Shimotohno K, Kaneko S, Murakami S.

J Virol. 2006 Apr;80(7):3332-40.

20.

Transcriptomic comparison of human hepatoma Huh-7 cell clones with different hepatitis C virus replication efficiencies.

Inoue Y, Murakami K, Hmwe SS, Aizaki H, Suzuki T.

Jpn J Infect Dis. 2007 Jul;60(4):173-8.

Supplemental Content

Support Center